Friday, February 26, 2021
Corporate Compliance Insights
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Articles
    • See All Articles
    • NEW: COVID-Related
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Leadership and Career
  • Vendor News
  • Jobs
    • Compliance & Risk
    • Information Security
  • Events
    • Webinars & Events
    • Submit an Event
  • Downloads
    • eBooks
    • Whitepapers
  • Podcasts
  • Videos
  • Subscribe
No Result
View All Result
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Articles
    • See All Articles
    • NEW: COVID-Related
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Leadership and Career
  • Vendor News
  • Jobs
    • Compliance & Risk
    • Information Security
  • Events
    • Webinars & Events
    • Submit an Event
  • Downloads
    • eBooks
    • Whitepapers
  • Podcasts
  • Videos
  • Subscribe
No Result
View All Result
Corporate Compliance Insights
Home GRC Vendor News

Conselium Executive Search: Teva Pharmaceuticals Names Compliance Officer in Amsterdam

by Corporate Compliance Insights
July 7, 2014
in GRC Vendor News
Conselium Executive Search: Teva Pharmaceuticals Names Compliance Officer in Amsterdam

Conselium, an executive search firm, has completed a search on behalf of Teva Pharmaceuticals.  Ms. Astrid Amelink began her role of Director Medical Affairs Compliance Europe on April 21 in the company’s office in Amsterdam, Netherlands.

Ms. Amelink’s Responsibilities include:

  • Partnering in the development, implementation and maintenance of policies and procedures
  • Provide strategic compliance consulting to members of EU Medical Affairs Management
  • Advising on medical science liaison interactions, phase IIIb and IV clinical trials, investigator-sponsored studies, health economics/outcomes measures, medical information, medical convention booth conduct, medical education, and sponsorships
  • Ensuring review and approval of activities relevant to EU healthcare professional (HCP) interactions
  • Design/implement MA compliance training and effective communication
  • Participate in implementation of EU risk management plans to identify and mitigate compliance risks
  • Collaborating with business partners towards aggregate spend methodology and accuracy
  • Leading the investigation of compliance-related incidents

Ms. Amelink held previous Compliance Officer positions for Merck and Biogen Idec.

The backbone of Teva Pharmaceutical Industries is its world-leading generic pharmaceuticals business. Through subsidiary Teva Pharmaceuticals USA, the company makes generic versions of brand-name antibiotics, heart drugs, heartburn medications, and more — in all about 300 generic products. Teva’s US generic products include equivalents of such blockbusters as antidepressant Prozac and cholesterol drug Mevacor. The company, Israel’s top drug maker, also develops and manufactures proprietary drugs, including multiple sclerosis treatment Copaxone and Parkinson’s disease treatment Azilect. Its active pharmaceutical ingredients division makes drug components for Teva and other pharmaceutical manufacturers.

 

 


Previous Post

In Due Diligence and World Cup Bids: Follow the Money

Next Post

Impossible to Ignore: The Importance of IT Governance

Corporate Compliance Insights

Related Posts

red paper plane breaking rank from white paper planes

Diligent to Become Largest Global GRC SaaS Company Through Galvanize Acquisition

February 24, 2021
gold cup award on red background with stars

Ethisphere Announces the 2021 World’s Most Ethical Companies

February 23, 2021
hands fitting puzzle pieces together on yellow background

LexisNexis® Risk Solutions and Accuity Join Operations

February 18, 2021
concept next generation technology

NICE Launches Next-Gen Compliance Solution

February 1, 2021
Next Post
Impossible to Ignore: The Importance of IT Governance

Impossible to Ignore: The Importance of IT Governance

Access realtime data
Addressing systemic racism in the workplace SAI Global
Dynamic Risk Assessments with Workiva
Top 10 Risk and Compliance Trends

Special Coverage

Special COVID page graphic

Jump to a Topic:

anti-corruption anti-money laundering/AML Artificial Intelligence/A.I. automation banks board of directors board risk oversight bribery CCPA/California Consumer Privacy Act Cloud Compliance communications management Coronavirus/COVID-19 corporate culture crisis management cyber crime cyber risk data analytics data breach data governance decision-making diversity DOJ due diligence fcpa enforcement actions financial crime GDPR GRC HIPAA information security KYC/know your customer machine learning monitoring ransomware regtech reputation risk risk assessment Sanctions SEC social media risk supply chain technology third party risk management tone at the top training whistleblowing
No Result
View All Result

Privacy Policy

Follow Us

  • Facebook
  • Twitter
  • LinkedIn
  • RSS Feed

Category

  • CCI Press
  • Compliance
  • Compliance Podcasts
  • Cybersecurity
  • Data Privacy
  • eBooks
  • Ethics
  • FCPA
  • Featured
  • Financial Services
  • Fraud
  • Governance
  • GRC Vendor News
  • HR Compliance
  • Internal Audit
  • Leadership and Career
  • Opinion
  • Resource Library
  • Risk
  • Uncategorized
  • Videos
  • Webinars
  • Whitepapers

© 2019 Corporate Compliance Insights

No Result
View All Result
  • Home
  • About
  • Articles
  • Vendor News
  • Podcasts
  • Videos
  • Whitepapers
  • eBooks
  • Events
  • Jobs
  • Subscribe

© 2019 Corporate Compliance Insights